After treatment with celecoxib or placebo, the protein expression of Ki-67, COX-2, cleaved caspase-3 and matrix metalloproteinase-9 (MMP9) in the ovarian tumors was evaluated by immunohistochemistry (IHC) (Figure 4E). This evidence concerns the gene MMP9 and ovarian neoplasm.